3rd Quarter - Report — AMERICAN THORACIC SOCIETY for AMERICAN THORACIC SOCIETY (2025)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

AMERICAN THORACIC SOCIETY

Client

AMERICAN THORACIC SOCIETY

Income

—

Expenses

$50,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
3rd Quarter - Report (this page)	Nov 6, 2025	$50,000	Replaced
3rd Quarter - Amendment	Mar 13, 2026	$50,000	Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Clean Air and Water (quality) CAW

Clean Air Act

Lobbyist	Covered position, as disclosed
GARY WARREN EWART	—

Contacted: Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

NIH funding Medicare Supplemental oxygen CDC funding Medicaid

Lobbyist	Covered position, as disclosed
GARY WARREN EWART	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH)

Tobacco TOB

Regulation of tobacco products

Lobbyist	Covered position, as disclosed
GARY WARREN EWART	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Veterans VET

VA research funding

Lobbyist	Covered position, as disclosed
GARY WARREN EWART	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Veterans Affairs, Dept of (VA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.